Oncology: the power of holistic insights

Understanding why real-world treatment in oncology can be sub-optimal – and what can be done about it.

The author(s)

  • Chris Teale Senior Vice President, Market Access, UK
  • Alessandra Franceschetti Global Oncology Monitor, UK
  • Ayse Levent Molecular Diagnostics Monitor, US
  • Pete Duncan Healthcare Social Intelligence Analytics Centre of Excellence, UK
Get in touch

Ipsos | power of holistic insights | health | patientsTraditionally, research into the treatment of patients focuses purely on the healthcare professional perspective – but, crucially, this does not always reflect treatment in the real world which is influenced by multiple stakeholders and myriad external factors…

In our paper and recent webinar, Ipsos uses multiple data sources to illustrate why the treatment of breast cancer in the real world may deviate from current treatment guidelines. Specifically, we draw on:

  • Physician insights
    Real-world evidence (RWE) from doctors treating breast cancer
  • Pathologist insights
    Perspectives on biomarker testing in breast cancer
  • Patient insights
    Social intelligence analysis of breast cancer patients’ attitudes and unmet needs
  • Payer insights
    Expert guidance from Ipsos’ market access team on the payer perspective

We go on to explore the different approaches and frameworks that can enable the integration of these insights and generate a holistic view – and, ultimately, hypothesise on why these disparities may exist and what can be done about it.

Download
the full paper

Watch the webinar

The author(s)

  • Chris Teale Senior Vice President, Market Access, UK
  • Alessandra Franceschetti Global Oncology Monitor, UK
  • Ayse Levent Molecular Diagnostics Monitor, US
  • Pete Duncan Healthcare Social Intelligence Analytics Centre of Excellence, UK

More insights about Health

Society